Cocrystal Melting Point Elevation for API Processing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The substituted 2-oxo-1-pyrrolidinyl triazole compound of formula (I) has a low melting point, making particle-size reduction and formulation challenging, and it does not form simple salts due to non-protonatable nitrogen atoms, limiting the development of stable pharmaceutical forms for cognitive impairment treatment.
Innovation Solution
Formation of cocrystals with a carboxylic acid coformer, such as those of formula (II), which enhances the melting point, stability, and processing properties, including non-hygroscopicity and high purity, facilitating particle size reduction and downstream processing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Temperature
If the substituted 2-oxo-1-pyrrolidinyl triazole compound is used in its pure form, then the compound maintains its chemical integrity, but the low melting point (approximately 85°C) makes particle-size reduction and formulation challenging
Solution Approach 1:
The patent forms a cocrystal composite material by combining the substituted 2-oxo-1-pyrrolidinyl triazole compound with a carboxylic acid coformer. This composite cocrystal structure raises the melting point to over 25°C higher than the pure API, thereby improving particle-size reduction capability and downstream processing while maintaining chemical integrity through the stable crystalline lattice.
2Ease of manufacture
If simple salt formation is attempted with the substituted 2-oxo-1-pyrrolidinyl triazole compound, then the option of forming a crystalline salt is available, but the nitrogen atoms are not easily protonated, making salt formation not available
Solution Approach 1:
The patent uses a carboxylic acid coformer as an intermediary to achieve crystalline salt-like stability without requiring protonation of the nitrogen atoms. The cocrystal formation creates a stable crystalline lattice through non-covalent interactions between the API and coformer, providing the benefits of crystalline salts without the need for traditional acid-base salt formation.
3Ease of manufacture
If the substituted 2-oxo-1-pyrrolidinyl triazole compound is formulated as a cocrystal with a carboxylic acid coformer, then the melting point increases and processing properties improve, but the identification of suitable coformers becomes challenging
Solution Approach 1:
The patent employs systematic parameter changes in the coformer selection process, focusing on carboxylic acids with specific structural parameters (formula II with varying n values and L groups). This structured approach to parameter variation enables identification of suitable coformers that optimize melting point and processing properties while maintaining crystalline stability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The cocrystals exhibit improved melting points, stability, and processing characteristics, enabling more effective formulation and storage of the substituted 2-oxo-1-pyrrolidinyl triazole compound for pharmaceutical applications, particularly in treating cognitive disorders.
Implementation Method 1
The present invention provides cocrystals of the substituted 2-oxo-1-pyrrolidinyl triazole compound of formula (I) with improved physical properties compared to the pure compound
Implementation Method 2
the cocrystals of the present invention have a higher melting point than that of the pure API. Indeed, particular cocrystals of the invention exhibit melting points over 25° C. higher than that of the API
Implementation Method 3
improving the crystallinity and powder flow properties of the API
Data Source
AI summary
The invention relates to cocrystals comprising a substituted 2-oxo-1-pyrrolidinyl triazole of formula (I) and a carboxylic acid of formula (II).


